Stay updated on PET-Directed Therapy With Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PET-Directed Therapy With Pembrolizumab Clinical Trial page.

Latest updates to the PET-Directed Therapy With Pembrolizumab Clinical Trial page
- CheckyesterdayChange DetectedAdded Locations sections for California, Georgia, Illinois, and New Jersey. Removed the HHS Vulnerability Disclosure entry and existing state location entries; revision updated to v3.3.3.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no other content changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedPublications section now notes that PubMed entries are automatically filled and may not be about the study, and the revision version is updated to v3.3.1 (previously v3.2.0).SummaryDifference0.1%

- Check37 days agoChange DetectedThe banner notice about government funding lapses and NIH operating status has been removed. The study information on the page remains unchanged.SummaryDifference0.3%

- Check51 days agoChange DetectedNo significant changes detected between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check80 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.1%

Stay in the know with updates to PET-Directed Therapy With Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PET-Directed Therapy With Pembrolizumab Clinical Trial page.